ChatGPT Ads: What Telehealth Brands Should Know Before Advertising in AI Search

Healthcare advertising in ChatGPT remains restricted at launch, and approval rules are still being defined. But here is what the expansion clearly means: AI conversation-based advertising is becoming a real paid media channel, and telehealth operators who understand it now will be better positioned than competitors who discover it later.

This article covers what ChatGPT ads are, how the platform works, what the current restrictions mean for healthcare businesses, and how a telehealth infrastructure company like Bask Health should approach this channel before it opens.

What Are ChatGPT Ads?

ChatGPT ads are sponsored placements that appear within ChatGPT conversations, where people ask questions, compare options, and make decisions in a conversational format.

When a user's conversation has commercial intent, a clearly labeled sponsored placement can appear beneath ChatGPT's organic answer. The key distinction from traditional search ads is that the ad matches the context of a specific conversation, not just a keyword. A user asking a detailed, specific question signals intent in a way a short search query rarely can.

OpenAI began testing ads in late 2025 for logged-in adult users on its Free and Go subscription tiers. By May 2026, OpenAI had expanded ChatGPT ads through a self-serve beta Ads Manager, CPC bidding, and broader access for agencies and partners. The rollout is still evolving, so advertisers should treat availability and category eligibility as moving targets.

What Changed in May 2026

Until recently, entering the ChatGPT ads program required a direct relationship with OpenAI's team and a minimum spend of $50,000. That has changed.

Here is what is new:

• Self-serve Ads Manager is live in beta for all U.S. advertisers. Businesses can register, set budgets, upload creative, and manage campaigns directly at ads.openai.com.
• The $50,000 minimum spend has been removed. Small businesses and startups can now participate without needing an enterprise contract.
• Cost-per-click (CPC) bidding is now available alongside the original CPM model, so advertisers only pay when users click, not just when ads appear.
• Ad-tech partners, including Pacvue, Kargo, StackAdapt, Criteo, and Adobe, allow buying through existing workflows.
• Agency access through Dentsu, Omnicom, Publicis, and WPP means most media teams can buy ChatGPT ads through their existing systems.

OpenAI reportedly generated over $100 million in U.S. ad revenue during just the first six weeks of its pilot. This is not an experimental side project; it is a real channel growing quickly.

ChatGPT Ads and Telehealth Compliance: The Real Constraint

Before anything else, telehealth brands need to understand where the current policy line sits.

OpenAI's ad content policies are explicit: healthcare advertising is currently disallowed at launch. This includes prescription drugs, clinical care providers, prescription services, hospitals, over-the-counter medications, and any ad making claims related to the prevention, diagnosis, or treatment of a health condition.

In OpenAI's own words, the initial ad categories are primarily limited to consumer verticals such as lifestyle and household goods, local services, travel and experiences, and digital products or education. Regulated categories, including healthcare, financial services, and gambling, are disallowed at this stage, though OpenAI has indicated these categories may expand over time as the platform matures.

There is one nuance worth noting. OpenAI updated its placement policy in April 2026 to clarify that medical, legal, and financial advice contexts are no longer categorically blocked from ads by default, meaning ads from permitted categories can appear near health-adjacent conversations. But the ad content itself for healthcare remains restricted.

What this means in practice: a telehealth clinic that runs ads directly promoting patient services, prescription access, or clinical treatment is not currently eligible. General health and wellness products that make no medical claims may be permitted in some cases, but telehealth operators should get a legal and compliance review before assuming their offer qualifies.

The main question for a telehealth brand is not whether ChatGPT ads are interesting. They clearly are. The real question is whether a specific offer, landing page, claim, and user context can simultaneously meet OpenAI's ad policies, healthcare advertising rules, and platform standards. That boundary is still being actively defined, and the businesses that invest in understanding it now will be far better positioned when the channel opens up further.

How ChatGPT Ads Actually Work

For brands evaluating this channel, a few key mechanics matter:

Ads don't influence ChatGPT's answers. OpenAI's "Answer Independence" principle is firm: responses are determined solely by what's helpful to the user. Sponsored placements appear separately, clearly labeled, and below the organic answer, never embedded within it.

Contextual targeting, not surveillance. Ads are matched based on the topic of the current conversation. Advertisers can provide "context hints" to guide relevance, but these are not exact-match keyword triggers. OpenAI controls the final delivery decision inside the conversation. For privacy-conscious industries, this matters: you are not buying access to personal health disclosures; you are buying contextual relevance.

Conversations stay private. OpenAI does not share individual conversations, chat history, or personal details with advertisers. Advertisers receive only aggregated, non-identifying performance data, such as total impressions and total clicks.

Paid users don't see ads. Plus, Pro, Business, Enterprise, and Education subscribers are ad-free. The addressable inventory is on Free and Go tiers, still representing a very large user base.

Personalized ads are optional. Users with memory enabled may see personalized ads based on past interactions, but this can be turned off at any time through the ad controls in settings.

Why ChatGPT Ads Are Different From Search Ads

Traditional search ads respond to typed keywords. ChatGPT ads respond to conversational context. That difference matters because users often explain their goals, constraints, and decision criteria in more detail when speaking with an AI assistant. For advertisers, this could eventually shift paid media strategy from keyword coverage toward intent interpretation, educational relevance, and landing page trust.

For telehealth brands, that does not remove compliance obligations. It makes them more important. A conversational ad environment may create stronger intent signals, but it also requires stricter guardrails around sensitive health topics, prescription-related claims, and user privacy expectations.

This section helps rank for related terms like ChatGPT advertising, AI search ads, and conversational advertising.

Where Bask Health Actually Fits

Bask Health is an infrastructure for the telehealth industry, not a direct-to-patient clinic. That distinction matters here.

The earliest opportunity for a platform like Bask Health on ChatGPT ads may not be direct prescription or clinical advertising. It may be education, software, and business services for healthcare entrepreneurs and clinic operators. Think:

• A healthcare entrepreneur asking how to launch a telehealth business
• A doctor researching what software powers a direct-to-consumer clinic
• A health brand founder looking for e-prescribing or fulfillment infrastructure
• A practice manager evaluating patient intake and EMR options

These conversations are business-to-business in nature and fall closer to the software, education, and professional services categories, which face fewer restrictions than clinical healthcare advertising.

This is where Bask Health should be watching the ChatGPT ads channel: not as a shortcut for patient acquisition, but as a possible future channel for category education, founder demand, and clinic-builder discovery. As OpenAI expands the supported ad categories, the policy landscape for telehealth infrastructure will look different from that for direct clinical care, and the brand that has been testing, learning, and preparing will have a significant head start.

The First-Mover Advantage Is About Learning, Not Just Placement

The "telehealth" category in ChatGPT ads is not yet fully open. But the way first-mover advantages work isn't about launching a campaign on day one. It is about learning velocity.

Brands that register now, study OpenAI's policy evolution, prepare compliant landing pages, test non-sensitive messaging, and understand how conversational ad matching works will be better positioned when healthcare categories become more broadly available.

The businesses most likely to secure meaningful placements in the future are those building their understanding of the platform now, not those scrambling to understand the platform after their competitors have already run six months of campaigns.

A Practical Compliance Roadmap for Telehealth Brands

If you want to prepare seriously, here is a reasonable starting framework:

Step 1: Register and read the policies. Create your advertiser account at ads.openai.com and read OpenAI's current ad content policies in full before building any campaign. Treat the policy document as a living document; it was updated in April 2026 and will continue to evolve.

Step 2: Get a legal and compliance review. Telehealth advertisers face a dual compliance challenge: OpenAI's platform policies and applicable healthcare regulations, including the FTC's health advertising guidelines, FDA requirements for drug or device claims, and state-level privacy laws. Consult compliance counsel before anything goes live.

Step 3: Identify your compliant use cases. Which of your offers, messaging, and landing pages can meet both platform and regulatory standards? For Bask Health, infrastructure and software messaging differ markedly from clinical outcome claims. Know where your line is before you build creative.

Step 4: Prepare creative and landing pages. Approved ad creative must be consistent end to end. OpenAI explicitly states that an approved ad cannot link to a destination that introduces disallowed content. Your landing page matters as much as your ad copy.

Step 5: Start with CPC, not CPM. CPC bidding means you pay only on clicks, which reduces risk on a new channel where conversion benchmarks are still unknown. Start small, measure, and build your understanding before scaling.

Step 6: Monitor policy changes. Assign someone to track OpenAI's advertiser policy updates. The healthcare category restrictions are described as potentially evolving when they do shift; you want to know immediately, not six weeks later.

The Bottom Line

ChatGPT ads are a real channel, growing fast, with serious revenue ambitions. For most direct telehealth advertisers, the channel is not fully open, yet clinical advertising in healthcare remains restricted at launch.

But for a telehealth infrastructure company like Bask Health, the opportunity to educate, reach clinic builders, and establish category presence now exists in adjacent verticals that are already supported. And for any telehealth brand watching this space, the time to understand the platform, prepare a compliant strategy, and build advertiser experience is before the restrictions lift, not after.

The channel is moving quickly. So should you.

Launch your telehealth business on Bask Health.

References

1. OpenAI. (n.d.). OpenAI Ads. OpenAI. https://ads.openai.com/